The pharmacy admits to wrong doing and will fork out more than $24 million to the federal government and the remainder will ...

CVS Health will pay $37.76 million to settle allegations it dispensed too many insulin pens to patients, and then obtained ...

A national pharmacy chain agreed to a $37.76 million settlement after federal investigators found it dispensed excess insulin ...

As part of the settlement, CVS admitted and accepted responsibility for certain conduct alleged by the government, including ...

United States Attorney for the Southern District of New York, Jay Clayton, Special Agent in Charge of the New York Regional Office of the U.S. Department of Health and Human Services Office of the ...

A record $37.8 million settlement closes a decade-long case alleging that CVS overbilled government health programs by ...

CVS Health agreed to pay $37.76 million to settle allegations that it dispensed too many insulin pens to patients and ...

CVS has settled a lawsuit for $37.76 million over claims of over-dispensing insulin pens and fraudulent billing.

For a decade, CVS knew it was skirting rules meant to limit overprescribing but did nothing to stop, according to the ...

Barriers to adherence include “complicated regimens, fear of injection pain, social embarrassment, lack of confidence about self-injection, perception of injectable therapy as inconvenient, and belief ...

Dublin, June 25, 2025 (GLOBE NEWSWIRE) -- The "United States Insulin Pens Market Size, Insights, Competitive Landscape, and Forecast, 2025 - 2033" report has been added to ResearchAndMarkets.com's ...

Rising Diabetes Rates and Digital InnovatioFuel European Insulin Pen Market Growth European Insulin Pen Market European ...